Therapeutic application of CCK2R-targeting PP-F11: influence of particle range, activity and peptide amount.

Konijnenberg, Mark W; Breeman, Wout A P; de Blois, Erik; Chan, Ho Sze; Boerman, Otto C; Laverman, Peter; Kolenc-Peitl, Petra; Melis, Marleen; de Jong, Marion

Konijnenberg, Mark W; Breeman, Wout A P; de Blois, Erik; Chan, Ho Sze; Boerman, Otto C; Laverman, Peter; Kolenc-Peitl, Petra; Melis, Marleen; de Jong, Marion.

Affiliation

Konijnenberg MW; Department of Nuclear Medicine, Erasmus MC, PO Box 2040, 3000, CA, Rotterdam, The Netherlands, m.konijnenberg@erasmusmc.nl.

EJNMMI Res ; 4(1): 47, 2014 Dec.

Article in En | MEDLINE | ID: mdl-26116111

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452684
https://dx.doi.org/10.1186/s13550-014-0047-1

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: EJNMMI Res Year: 2014 Document type: Article

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452684
https://dx.doi.org/10.1186/s13550-014-0047-1

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: EJNMMI Res Year: 2014 Document type: Article